Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.3M | $10.5M | $10.1M | $10.4M | $11.6M | $10.5M | $10.5M | $9.2M |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $11.3M | $10.5M | $10.1M | $10.4M | $11.6M | $10.5M | $10.5M | $9.2M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $5.3M | $4.4M | $3.6M | $4.0M | $5.0M | $2.9M | $2.9M | $2.2M |
| EBITDA | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $109.4M |
| Net income | $47.4M | $75.6M | $95.9M | $9.7M | $66.7M | $142.4M | −$101.5M | $111.6M |
| Net margin | 419.3% | 718.6% | 946.8% | 93.1% | 576.3% | 1353.2% | -967.4% | 1213.7% |
| EPS (diluted) | 1.21 | 1.93 | 2.44 | 0.25 | 1.70 | 3.62 | -2.53 | 2.77 |
Annual figures · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| PYVAXPayden Equity Income Fund Adviser Cl | $18.46 | +0.05% | $1.3B | — |
| ABCVXAmerican Beacon The London Company Income Equity Fund Investor Class | $23.41 | +0.43% | $1.1B | — |
| BMDIXBaird Mid Cap Growth Fund - Institutional Class | $20.79 | +0.39% | $1.2B | — |
| BMDSXBaird Mid Cap Growth Fund - Investor Class | $18.45 | +0.38% | $1.2B | — |
| EOSEaton Vance Enhanced Equity Income Fund II |
No one on the platform currently holds PYVAX.
No tracked institution reports a position in PYVAX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-29 | $0.0402 | 2026-06-29 |
| 2026-03-30 | $0.0566 | 2026-03-30 |
| 2025-12-30 | $0.0401 | 2025-12-30 |
| 2025-12-23 | $0.8756 | 2025-12-23 |
| 2025-09-29 | $0.0470 | 2025-09-29 |
| 2025-06-27 | $0.0423 | 2025-06-27 |
| 2025-03-28 | $0.0373 | 2025-03-28 |
| 2024-12-30 | $0.0347 | 2024-12-30 |
| 2024-12-23 | $2.6338 | 2024-12-23 |
| 2024-09-27 | $0.0509 | 2024-09-27 |
| 2024-06-27 | $0.0658 |
No one on the platform has traded PYVAX yet.
| $22.04 |
| +1.17% |
| $1.2B |
| — |
| FPFFirst Trust Intermediate Duration Preferred & Income Fund | $18.17 | +0.66% | $1.1B | — |
| PACIXColumbia Convertible Securities Fund Class A | $30.45 | +0.59% | $1.9B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2024-06-27 |
| 2024-03-27 | $0.0753 | 2024-03-27 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.